Such disease recognition phenomena successfully made possible by the model of molecular medicine have been used as a foundation in discussing aging, Alzheimer and Parkinson's diseases concerning the importance of the models (Petersen, 2003).
In general, the idea presented in this project helps understand how experimentation of different genes in the model has helped in disease identification and treatment (North & Greenspan, 2007). A model organism is a difficult and practical study of non-human species in research of human disease identification specifically when human experimentation is regarded as unethical. Thus, strategic methods used in model organisms combine all common descent of living organisms (vertebrates and invertebrates) such as developmental pathways, genetic material, and metabolic conservation to provide insight or information in studying other related animals (Dittmer, 2012).
The animal model system is commonly used in molecular medicine in disease identification. Organisms with sources of biological data are selectively identified to analyze other animals that are more complex to analyze directly. In simple terms, animals’ natural behaviors, biomechanical characteristics, and biological functions of individual components such as organelles, tissues, and proteins are examined for experimental manipulation. In molecular medicine, the discoveries removed from the research are then converted to the understanding of disease etiology, causes, clinical symptoms, prevention, and treatment (North & Greenspan, 2007). Therefore, vertebrates and invertebrate model systems examination serve as a turning point in molecular medicine as it helps to understand all molecular structures and mechanisms to develop molecular remedial medical interventions. In simple words, It is the onset of disease diagnosis, prevention, and treatment in respect of molecular medicine studies (Raffa & Rawls, 2008).